These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


743 related items for PubMed ID: 24084489

  • 1. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH, Negishi K, Grimm RA, Popovic Z, Stanton T, Wilkoff BL, Marwick TH.
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [Abstract] [Full Text] [Related]

  • 2. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka DP.
    J Am Coll Cardiol; 2012 Apr 24; 59(17):1509-18. PubMed ID: 22405632
    [Abstract] [Full Text] [Related]

  • 3. Predicting Clinical and Echocardiographic Response After Cardiac Resynchronization Therapy With a Score Combining Clinical, Electrocardiographic, and Echocardiographic Parameters.
    Bernard A, Menet A, Marechaux S, Fournet M, Schnell F, Guyomar Y, Leclercq C, Mabo P, Fauchier L, Donal E.
    Am J Cardiol; 2017 Jun 01; 119(11):1797-1802. PubMed ID: 28400028
    [Abstract] [Full Text] [Related]

  • 4. Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy.
    Mele D, Nardozza M, Malagù M, Leonetti E, Fragale C, Rondinella A, Ferrari R, Bertini M.
    J Am Soc Echocardiogr; 2017 Oct 01; 30(10):1001-1011. PubMed ID: 28822669
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC, Höke U, Thijssen J, Willem Borleffs CJ, Wolterbeek R, Schalij MJ, van Erven L.
    Am J Cardiol; 2016 Oct 15; 118(8):1217-1224. PubMed ID: 27586169
    [Abstract] [Full Text] [Related]

  • 6. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
    St John Sutton M, Linde C, Gold MR, Abraham WT, Ghio S, Cerkvenik J, Daubert JC, REVERSE Study Group.
    JACC Heart Fail; 2017 Mar 15; 5(3):169-178. PubMed ID: 28254122
    [Abstract] [Full Text] [Related]

  • 7. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S, Goldenberg I, Moss AJ, Solomon S, Kutyifa V, McNitt S, Shah AH, Huang DT, Aktas MK, Zareba W, Barsheshet A.
    Am J Cardiol; 2014 Oct 01; 114(7):1053-8. PubMed ID: 25118116
    [Abstract] [Full Text] [Related]

  • 8. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
    Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, Shinn T, Solomon S, Steinberg JS, Wilber D, Barsheshet A, McNitt S, Zareba W, Klein H, MADIT-CRT Executive Committee.
    Circulation; 2011 Oct 04; 124(14):1527-36. PubMed ID: 21900084
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular scar impact on left ventricular synchronization parameters and outcomes of cardiac resynchronization therapy.
    Ahmed W, Samy W, Tayeh O, Behairy N, Abd El Fattah A.
    Int J Cardiol; 2016 Nov 01; 222():665-670. PubMed ID: 27517660
    [Abstract] [Full Text] [Related]

  • 10. Left atrial function, a new predictor of response to cardiac resynchronization therapy?
    Feneon D, Behaghel A, Bernard A, Fournet M, Mabo P, Daubert JC, Leclercq C, Donal E.
    Heart Rhythm; 2015 Aug 01; 12(8):1800-6. PubMed ID: 25896013
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
    Auger D, van Bommel RJ, Bertini M, Delgado V, Ng AC, Ewe SH, Shanks M, Marsan NA, Mooyaart EA, Witkowski T, Poldermans D, Schalij MJ, Bax JJ.
    Am Heart J; 2010 Oct 01; 160(4):737-43. PubMed ID: 20934569
    [Abstract] [Full Text] [Related]

  • 12. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E, Biagioli P, Alunni G, Murrone A, Pantano P, Biscottini E, Zuchi C, Zingarini G, Cavallini C, Ambrosio G.
    JACC Cardiovasc Imaging; 2011 Oct 01; 4(10):1067-76. PubMed ID: 21999865
    [Abstract] [Full Text] [Related]

  • 13. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy.
    Kydd AC, Khan FZ, Ring L, Pugh PJ, Virdee MS, Dutka DP.
    Eur J Heart Fail; 2014 Nov 01; 16(11):1206-13. PubMed ID: 25302484
    [Abstract] [Full Text] [Related]

  • 14. E/A ratio before cardiac resynchronization therapy predicts left ventricle reverse remodeling.
    Iori M, Bottoni N, Quartieri F, Manari A.
    Minerva Cardioangiol; 2014 Aug 01; 62(4):305-9. PubMed ID: 25012099
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
    Wang CL, Powell BD, Redfield MM, Miyazaki C, Fine NM, Olson LJ, Cha YM, Espinosa RE, Hayes DL, Hodge DO, Lin G, Friedman PA, Oh JK.
    Eur J Heart Fail; 2012 May 01; 14(5):517-25. PubMed ID: 22411692
    [Abstract] [Full Text] [Related]

  • 16. Differentiating Electromechanical From Non-Electrical Substrates of Mechanical Discoordination to Identify Responders to Cardiac Resynchronization Therapy.
    Lumens J, Tayal B, Walmsley J, Delgado-Montero A, Huntjens PR, Schwartzman D, Althouse AD, Delhaas T, Prinzen FW, Gorcsan J.
    Circ Cardiovasc Imaging; 2015 Sep 01; 8(9):e003744. PubMed ID: 26338877
    [Abstract] [Full Text] [Related]

  • 17. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A, Abreu-Gonzalez P, Piccolo R, Galasso G, Reiter RJ.
    Int J Cardiol; 2016 Oct 15; 221():359-63. PubMed ID: 27404706
    [Abstract] [Full Text] [Related]

  • 18. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M, Zwicker C, Kaminski M, Napp A, Altiok E, Ocklenburg C, Friedman Z, Adam D, Schauerte P, Marx N, Hoffmann R.
    JACC Cardiovasc Imaging; 2011 Apr 15; 4(4):366-74. PubMed ID: 21492811
    [Abstract] [Full Text] [Related]

  • 19. Mechanical abnormalities detected with conventional echocardiography are associated with response and midterm survival in CRT.
    Doltra A, Bijnens B, Tolosana JM, Borràs R, Khatib M, Penela D, De Caralt TM, Castel MÁ, Berruezo A, Brugada J, Mont L, Sitges M.
    JACC Cardiovasc Imaging; 2014 Oct 15; 7(10):969-79. PubMed ID: 25240452
    [Abstract] [Full Text] [Related]

  • 20. Three-dimensional propagation imaging of left ventricular activation by speckle-tracking echocardiography to predict responses to cardiac resynchronization therapy.
    Seo Y, Ishizu T, Kawamura R, Yamamoto M, Kuroki K, Igarashi M, Sekiguchi Y, Nogami A, Aonuma K.
    J Am Soc Echocardiogr; 2015 May 15; 28(5):606-14. PubMed ID: 25797706
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.